Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Once and future Chief Counsel

This article was originally published in The Tan Sheet

Executive Summary

Gerald Masoudi returns from the Justice Department to become FDA chief counsel/associate general counsel effective Oct. 12. He replaces Sheldon Bradshaw, who left the agency Sept. 12 to join the Washington, D.C. firm Hunton & Williams (1"The Tan Sheet" Sept. 10, 2007, In Brief). The role will be a familiar one for Masoudi, who came to FDA in 2004 as deputy chief counsel and was acting chief counsel for several months before Bradshaw was named to the post (2"The Tan Sheet" April 11, 2005, p. 7). Since 2005, Masoudi has been deputy assistant attorney general in charge of International, Policy and Appellate Matters in the Antitrust Division at the U.S. Department of Justice. Before joining FDA, Masoudi was a partner at Kirkland & Ellis, where his background included antitrust work (3"The Tan Sheet" Nov. 15, 2004, p. 12)...
Advertisement
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS101029

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel